Integrated BioPharma, Inc. Financial Ratios — INBP Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-16.59	-21.26	0.76	1.08	6.33	7.49	16.1	4.56	9.83	19.23	33.12	15.14	-0.13	0.43	3.16
Return on Capital (%)	- -	- -	-2.28	-1.76	-3.9	-4.48	- -	-3.69	-6.25	- -	- -	- -	0.16	-0.37	-2.66
Return on Invested Capital (%)	- -	- -	23.03	18.23	17.84	28.11	- -	12.27	18.54	- -	- -	- -	-0.19	0.49	3.74
Gross Margin (%)	24.99	20.78	16.36	14.5	11.72	13.04	14.2	11.41	12.45	12.75	14.92	11.65	8.01	7.72	10.23
EBITDA Margin (%)	0.32	-0.02	4.58	5.17	3.57	5.84	7.62	4.67	6.96	7.64	10.4	6.36	2.51	2.93	6.05
Operating Margin (%)	-0.89	-1.38	3.32	4.01	2.49	5.01	6.79	3.88	5.41	6.18	9.1	4.88	0.24	0.5	3.72
Incremental Operating Margin (%)	- -	- -	-54.41	393.33	-11.01	24.99	22.64	46.02	16.12	19.88	23.4	41.56	47.09	-36.9	43.83
Pretax Margin (%)	-5.55	-7.38	0.33	0.65	2.32	2.82	3.95	2.3	4.09	5.85	11.4	4.62	0.2	0.53	3.79
Profit Margin (%)	-5.61	-7.41	0.28	0.39	1.96	2.27	5	1.55	3.38	7.78	12.61	6.82	-0.07	0.22	1.49
Net Income to Common Margin (%)	-5.61	-7.41	0.28	0.39	1.96	2.27	5	1.55	3.38	7.78	12.61	6.82	-0.07	0.22	1.49
Effective Tax Rate (%)	- -	- -	15.45	40.45	15.42	19.43	- -	32.44	17.34	- -	- -	- -	134	58.21	60.81
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025

Total Debt	13	14	15	14	14	16	15	15	13	11	6	2	3	2	1
ST Debt	13	4	5	5	5	5	6	11	7	7	4	1	1	1	1
LT Debt	- -	9	10	9	9	10	9	4	6	4	2	1	2	1	- -
Total Debt/EBITDA	97.71	-2,277.83	9.86	8.08	10.64	6.3	4.26	7.13	3.71	2.76	0.91	0.57	2.1	1.22	0.31
Net Debt/EBITDA	92.09	-2,253.67	9.83	7.82	10.59	6.14	4.23	7.02	2.62	1.96	0.52	-0.04	-0.99	-1.14	-1.1
Total Debt/EBIT	-34.82	-27.01	13.62	10.41	15.27	7.34	4.79	8.6	4.77	3.42	1.04	0.75	22.27	7.16	0.5
Net Debt/EBIT	-32.82	-26.72	13.57	10.08	15.19	7.15	4.75	8.46	3.38	2.42	0.59	-0.05	-10.56	-6.68	-1.79
EBITDA to Interest Expense	0.07	-0.01	1.57	1.81	1.37	2.59	3.93	2.21	5.52	10.15	30.89	33.45	31.85	- -	- -
EBITDA-CapEx/Interest Expense	-0.09	-0.15	1.54	1.62	1.13	2.47	3.57	1.94	4.86	9.61	29.51	28.91	28.95	- -	- -
EBIT to Interest Expense	-0.19	-0.46	1.14	1.4	0.95	2.22	3.5	1.83	4.29	8.21	27.03	25.65	3	- -	- -
Interest Expense	2	1	1	1	1	1	1	1	1	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-381.97	-461.83	-434.22	-471.62	-463.68	-379.49	-332.91	-342.6	-243.58	-192.19	-141.84	-127.7	-126.93	-122.74	-125.93
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	292.87	62.27	13.05	7.6	9.24	4.4	1.65
Long-Term Debt/Capital (%)	- -	-23.05	-24.75	-23.1	-22.85	-27.83	-26.8	-10.25	-15.7	-11.46	-6.22	-4.68	-5.88	-2.79	-1.11
Long-Term Debt/Total Assets (%)	- -	79.94	77.62	80.88	77.97	74.65	62.3	24.88	28.01	16.47	7.35	5.59	6.85	3.23	1.35
Total Debt/Equity (%)	-163.81	-131.63	-147.72	-138.62	-152.89	-186.38	-257.4	-278.07	681.19	183.53	41.86	11.06	14.17	9.35	5
Total Debt/Capital (%)	-31.88	-33.18	-38.42	-34.71	-35.92	-41.48	-43.2	-41.19	-36.52	-33.78	-19.94	-6.81	-9.02	-5.92	-3.35
Total Debt/Total Assets (%)	92.34	115.07	120.53	121.53	122.54	111.26	100.43	99.95	65.16	48.53	23.58	8.14	10.51	6.86	4.08
Net Debt to Equity	-154.39	-130.23	-147.18	-134.18	-152.13	-181.64	-255.17	-273.72	482.2	130.26	23.86	-0.78	-6.72	-8.72	-17.79
Net Debt/Capital (%)	-29.51	-32.72	-38.23	-33.23	-35.68	-40	-42.66	-40.28	-25.51	-23.69	-11.29	0.48	4.1	5.23	10.65
EBITDA	- -	- -	2	2	1	2	4	2	3	4	7	4	1	1	3
EBITDA-CapEx	- -	- -	2	2	1	2	3	2	3	4	6	3	1	1	3
Operating Income (Loss)	- -	-1	1	1	1	2	3	2	3	3	6	3	- -	- -	2

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025

Cash Ratio	0.07	0.08	0.06	0.08	0.05	0.08	0.05	0.01	0.04	0.03	0.02	0.06	0.27	0.27	0.85
Current Ratio	0.5	0.71	0.8	0.79	0.79	1.02	1.13	0.76	1.14	1.26	1.95	3.16	3.39	2.92	4.42
Quick Ratio	0.14	0.25	0.25	0.27	0.27	0.34	0.41	0.25	0.4	0.45	0.65	0.99	1.21	1.04	2.13
CFO/Avg Current Liab	0.02	-0.05	-0.12	0.16	-0.01	-0.05	0.03	0.09	0.02	0.11	0.27	0.56	0.24	0.17	0.4
Common Equity/Total Assets	-381.97	-461.83	-434.22	-471.62	-463.68	-379.49	-332.91	-342.6	-243.58	-192.19	-141.84	-127.7	-126.93	-122.74	-125.93
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	292.87	62.27	13.05	7.6	9.24	4.4	1.65
Long-Term Debt/Capital (%)	- -	-23.05	-24.75	-23.1	-22.85	-27.83	-26.8	-10.25	-15.7	-11.46	-6.22	-4.68	-5.88	-2.79	-1.11
Long-Term Debt/Total Assets (%)	- -	79.94	77.62	80.88	77.97	74.65	62.3	24.88	28.01	16.47	7.35	5.59	6.85	3.23	1.35
Total Debt/Equity (%)	-163.81	-131.63	-147.72	-138.62	-152.89	-186.38	-257.4	-278.07	681.19	183.53	41.86	11.06	14.17	9.35	5
Total Debt/Capital (%)	-31.88	-33.18	-38.42	-34.71	-35.92	-41.48	-43.2	-41.19	-36.52	-33.78	-19.94	-6.81	-9.02	-5.92	-3.35
Total Debt/Total Assets (%)	92.34	115.07	120.53	121.53	122.54	111.26	100.43	99.95	65.16	48.53	23.58	8.14	10.51	6.86	4.08
CFO/Total Liabilities	1.84	-3.46	-6.28	8.63	-0.54	-2.67	1.88	5.9	1.83	7.93	27.46	61.29	18.75	13.53	45.05
CFO/CapEx	1.3	-4.97	-47.93	10.31	-0.48	-5.45	1.21	4.73	0.79	6.26	10.34	8.42	10.62	1.71	10.07
Altman's Z-Score	-3.7	-4.25	-3.57	-3.72	-3.44	-1.74	-0.67	-1.64	-0.11	0.72	3.44	2.67	1.68	1.31	2.8

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025

Accounts Receivable Turnover	29.4	21.28	15.1	14.65	15.56	14.62	13.12	11.18	12.14	10.61	11.27	10.55	10.78	10.96	10.77
Days Sales Outstanding	12.41	17.15	24.18	24.91	23.45	24.96	27.81	32.63	30.07	34.4	32.4	34.6	33.85	33.29	33.91
Inventory Turnover	5.16	4.57	4.8	4.75	5.77	5.42	5.23	5.03	5.28	4.87	4.96	4.37	4.37	4.32	4.74
Days Inventory Outstanding	70.67	79.84	76.06	76.86	63.28	67.28	69.77	72.52	69.07	74.99	73.55	83.55	83.46	84.52	77.08
Accounts Payable Turnover	5.71	3.85	4.78	4.97	6.26	7.29	8.33	9.29	11.15	11.52	14.18	14.63	16.74	19.86	19.64
Accounts Payable Turnover Days	63.96	94.71	76.35	73.37	58.31	50.08	43.82	39.31	32.72	31.67	25.75	24.95	21.81	18.38	18.58
Cash Conversion Cycle	19.13	2.28	23.89	28.4	28.43	42.16	53.76	65.84	66.42	77.72	80.21	93.2	95.5	99.43	92.4
Inventory to Cash Days	-58.26	-62.69	-51.89	-51.95	-39.83	-42.32	-41.96	-39.88	-39	-40.6	-41.16	-48.95	-49.61	-51.23	-43.17
Inventories	7	5	6	6	6	8	8	8	9	10	12	11	10	11	9
Raw Materials	3	3	3	3	2	4	4	4	5	7	8	8	7	8	6
Work In Process	2	1	2	1	2	2	2	2	2	3	3	2	2	2	3
Finished Goods	3	1	2	2	1	2	2	1	2	1	1	1	1	1	1
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025

Market Capitalization	2	2	3	5	2	2	4	3	7	13	33	15	10	6	11
- Cash & Cash Equivalents	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	2	4
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	13	14	15	14	14	16	15	15	13	11	6	2	3	2	1
Enterprise Value	13	15	18	18	15	17	19	18	19	24	38	17	11	6	8
Total Capital	-40	-41	-40	-41	-40	-37	-35	-35	-35	-33	-30	-30	-30	-30	-30
Total Debt/Capital (%)	-31.88	-33.18	-38.42	-34.71	-35.92	-41.48	-43.2	-41.19	-36.52	-33.78	-19.94	-6.81	-9.02	-5.92	-3.35
Total Debt / EV	0.97	0.94	0.86	0.77	0.92	0.92	0.82	0.83	0.68	0.46	0.16	0.12	0.24	0.28	0.12
EV/Sales	0.32	0.4	0.52	0.55	0.41	0.4	0.4	0.4	0.38	0.46	0.61	0.29	0.22	0.13	0.15
EV/EBITDA	101.02	- -	11.44	10.54	11.56	6.87	5.22	8.62	5.48	5.96	5.82	4.63	8.82	4.37	2.5
EV/EBIT	- -	- -	15.79	13.58	16.58	8.02	5.86	10.39	7.05	7.38	6.65	6.04	93.66	25.64	4.07
EV/Cash Flow to Firm	5.54	42.35	- -	7.49	21.63	97.47	12.06	9.81	22.47	12.88	11.7	3.9	9.22	6.82	3.98
EV/Free Cash Flow to Firm	4.91	29.16	- -	6.97	16.28	59.91	9.96	8.62	15.1	11.55	10.74	3.5	8.42	4.3	3.62
Diluted Market Cap	2	2	3	5	2	2	6	5	7	14	35	16	10	6	11
Diluted Enterprise Value	14	15	18	19	17	17	21	19	19	25	41	18	11	7	9
EV per Share	0.63	0.69	0.84	0.87	0.73	0.8	0.88	0.83	0.66	0.81	1.29	0.56	0.38	0.21	0.27
TTM Sales	41	37	34	34	37	42	47	44	50	53	64	56	51	50	54
TTM EBITDA	- -	- -	2	2	1	2	4	2	3	4	7	4	1	1	3
TTM Operating Income	- -	-1	1	1	1	2	3	2	3	3	6	3	- -	- -	2
TTM Cash Flow to Firm	2	- -	-1	2	1	- -	2	2	1	2	3	4	1	1	2
TTM Free Cash Flow to Firm	3	- -	-1	3	1	- -	2	2	1	2	4	5	1	1	2

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025

Price/Free Cash Flow	2.85	-2.93	-2.26	2.57	20.47	-4.81	7.92	3.31	9.17	9.03	10.56	3.51	7.33	4.33	4.9
EV/EBIT	- -	- -	15.79	13.58	16.58	8.02	5.86	10.39	7.05	7.38	6.65	6.04	93.66	25.64	4.07
Enterprise Value	13	15	18	18	15	17	19	18	19	24	38	17	11	6	8
Low Price	0.02	0.02	0.09	0.1	0.07	0.08	0.04	0.11	0.1	0.18	0.26	0.27	0.27	0.17	0.16
EV/Sales	0.32	0.4	0.52	0.55	0.41	0.4	0.4	0.4	0.38	0.46	0.61	0.29	0.22	0.13	0.15
EV/EBITDA	101.02	- -	11.44	10.54	11.56	6.87	5.22	8.62	5.48	5.96	5.82	4.63	8.82	4.37	2.5
Price/Earnings	- -	- -	34	40.23	2.44	2.42	1.71	4.81	3.94	3.24	4.08	3.87	- -	56.37	13.39
Price/Earnings Average	-1.15	-0.42	41.48	29.77	4	2.2	1.66	5.49	2.57	2.17	2.86	7.19	-369.01	70.93	10.82
Price/Earnings High	-2.55	-2.56	61.2	51.5	9.76	2.97	3.06	6.85	4.3	3.67	4.63	9.13	-526.76	89.9	15.75
Price/Earnings Low	-0.23	-0.15	20.17	16.09	2.07	1.76	0.36	3.42	1.73	1.3	0.98	2.06	-237.84	45.64	6.14
Price/Book Value	-0.04	-0.03	-0.06	-0.1	-0.03	-0.04	-0.08	-0.07	-0.14	-0.3	-0.91	-0.46	-0.31	-0.2	-0.34
Price/Book Value Average	-0.05	-0.02	-0.07	-0.07	-0.05	-0.04	-0.08	-0.07	-0.09	-0.2	-0.63	-0.86	-0.39	-0.25	-0.28
Price/Book Value High	-0.11	-0.13	-0.1	-0.12	-0.13	-0.05	-0.14	-0.09	-0.15	-0.34	-1.03	-1.09	-0.55	-0.31	-0.41
Price/Book Value Low	-0.01	-0.01	-0.03	-0.04	-0.03	-0.03	-0.02	-0.05	-0.06	-0.12	-0.22	-0.24	-0.25	-0.16	-0.16
Price/Tangible Book Value	-0.22	-0.16	-0.28	-0.48	-0.18	-0.27	-0.66	-0.62	3.52	2.19	2.28	0.8	0.52	0.33	0.53
Price/Tangible Book Value Average	-0.29	-0.1	-0.34	-0.35	-0.29	-0.25	-0.64	-0.71	2.29	1.47	1.6	1.49	0.67	0.41	0.43
Price/Tangible Book Value High	-0.65	-0.6	-0.5	-0.61	-0.71	-0.33	-1.18	-0.88	3.84	2.49	2.59	1.89	0.95	0.52	0.63
Price/Tangible Book Value Low	-0.06	-0.04	-0.17	-0.19	-0.15	-0.2	-0.14	-0.44	1.54	0.88	0.55	0.43	0.43	0.27	0.24
Price/Sales	0.05	0.05	0.09	0.16	0.05	0.05	0.09	0.07	0.13	0.25	0.51	0.26	0.2	0.13	0.2
Price/Sales Average	0.06	0.03	0.11	0.12	0.08	0.05	0.08	0.09	0.09	0.17	0.36	0.49	0.25	0.16	0.16
Price/Sales High	0.14	0.19	0.17	0.2	0.19	0.07	0.15	0.11	0.15	0.29	0.58	0.62	0.35	0.2	0.23
Price/Sales Low	0.01	0.01	0.06	0.06	0.04	0.04	0.02	0.05	0.06	0.1	0.12	0.14	0.16	0.1	0.09
Price/Cash Flow	5.04	-2.34	-2.2	2.81	-15.88	-3.91	10.11	2.8	20.29	9.94	10.71	3.63	8.02	6.7	5.24
Price/Cash Flow Average	6.7	-1.47	-2.68	2.08	-26.01	-3.55	9.83	3.19	13.23	6.66	7.51	6.75	10.18	8.42	4.23
Price/Cash Flow High	14.84	-8.99	-3.96	3.59	-63.5	-4.8	18.09	3.98	22.14	11.26	12.17	8.57	14.54	10.68	6.16
Price/Cash Flow Low	1.33	-0.53	-1.3	1.12	-13.45	-2.84	2.13	1.99	8.89	3.98	2.58	1.93	6.56	5.42	2.4
Price/Free Cash Flow Average	3.79	-1.84	-2.76	1.9	33.54	-4.36	7.7	3.78	5.98	6.05	7.4	6.52	9.31	5.45	3.96
Price/Free Cash Flow High	8.4	-11.26	-4.07	3.29	81.9	-5.9	14.17	4.71	10.01	10.23	12	8.28	13.29	6.91	5.77
Price/Free Cash Flow Low	0.75	-0.66	-1.34	1.03	17.34	-3.5	1.67	2.36	4.02	3.62	2.54	1.87	6	3.51	2.25
EV/Sales Average	0.36	0.4	0.57	0.52	0.46	0.41	0.41	0.41	0.34	0.37	0.45	0.52	0.27	0.16	0.11
EV/Sales High	0.44	0.56	0.62	0.6	0.57	0.43	0.48	0.43	0.39	0.49	0.68	0.65	0.38	0.2	0.19
EV/Sales Low	0.3	0.38	0.51	0.47	0.42	0.4	0.34	0.38	0.31	0.3	0.21	0.17	0.19	0.1	0.04
EV/EBITDA Average	112.46	-2,442.49	12.33	10.06	12.79	6.99	5.32	8.85	4.82	4.88	4.34	8.19	10.91	5.48	1.87
EV/EBITDA High	137.2	-3,409.3	13.52	11.69	15.95	7.29	6.23	9.3	5.66	6.4	6.49	10.27	15.12	6.92	3.08
EV/EBITDA Low	96.12	-2,321.25	11.05	9.03	11.73	6.82	4.46	8.16	4.41	3.98	2.07	2.69	7.41	3.55	0.72
EV/EBIT Average	-40.08	-28.96	17.03	12.96	18.34	8.15	5.97	10.66	6.2	6.03	4.96	10.68	115.85	32.13	3.04
EV/EBIT High	-48.89	-40.43	18.67	15.07	22.88	8.5	7	11.21	7.28	7.92	7.42	13.39	160.55	40.6	5.01
EV/EBIT Low	-34.25	-27.52	15.25	11.64	16.82	7.95	5.01	9.83	5.67	4.93	2.36	3.5	78.69	20.85	1.17
Last Price	0.1	0.09	0.15	0.25	0.08	0.11	0.19	0.15	0.23	0.45	1.1	0.5	0.33	0.21	0.36
High Price	0.28	0.33	0.27	0.32	0.34	0.14	0.34	0.22	0.25	0.51	1.25	1.18	0.6	0.33	0.42
Enterprise Value Average	15	15	19	18	17	17	19	18	17	20	29	29	14	8	6
Enterprise Value High	18	20	21	20	21	18	22	19	20	26	43	37	19	10	10
Enterprise Value Low	12	14	17	16	16	17	16	17	15	16	14	10	9	5	2

Shares Outstanding	21	21	21	21	21	21	21	21	30	30	30	30	30	30	31
Diluted Weighted Avg Shares	21	21	21	21	29	21	30	30	30	31	32	32	30	31	31
Basic Weighted Avg Shares	21	21	21	21	21	21	21	21	29	30	30	30	30	30	30
Revenue per Share	1.96	1.74	1.6	1.6	1.78	2	2.22	2.07	1.73	1.78	2.14	1.89	1.69	1.67	1.79
EBITDA per Share	0.01	- -	0.07	0.08	0.06	0.12	0.17	0.1	0.12	0.14	0.22	0.12	0.04	0.05	0.11
Operating Income per Share	-0.02	-0.02	0.05	0.06	0.04	0.1	0.15	0.08	0.09	0.11	0.19	0.09	- -	0.01	0.07
Basic EPS, GAAP	-0.11	-0.13	- -	0.01	0.03	0.05	0.11	0.03	0.06	0.14	0.27	0.13	- -	- -	0.03
Basic EPS from Cont Ops	-0.11	-0.13	- -	0.01	0.03	0.05	0.11	0.03	0.06	0.14	0.27	0.13	- -	- -	0.03
Diluted EPS, GAAP	-0.11	-0.13	- -	0.01	0.03	0.05	0.08	0.02	0.06	0.13	0.25	0.12	- -	- -	0.03
Diluted EPS from Cont Ops	-0.11	-0.13	- -	0.01	0.03	0.05	0.08	0.02	0.06	0.13	0.25	0.12	- -	- -	0.03
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.02	-0.04	-0.07	0.09	-0.01	-0.03	0.02	0.06	0.01	0.05	0.1	0.14	0.04	0.03	0.07
Free Cash Flow per Basic Share	- -	-0.04	-0.07	0.08	-0.02	-0.03	- -	0.04	- -	0.04	0.09	0.12	0.04	0.01	0.06
Cash & Equivalents per Share	0.07	0.05	0.04	0.05	0.03	0.04	0.03	0.01	0.02	0.01	0.01	0.01	0.04	0.06	0.12
Book Value per Share	-2.51	-2.61	-2.6	-2.59	-2.55	-2.51	-2.4	-2.36	-1.67	-1.49	-1.21	-1.09	-1.08	-1.07	-1.04
Tangible Book Value per Share	-0.43	-0.55	-0.54	-0.52	-0.48	-0.41	-0.29	-0.25	0.07	0.21	0.48	0.63	0.63	0.64	0.67

Integrated BioPharma, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)